(PharmaNewsWire.Com, February 26, 2018 ) The global autosamplers market is projected to reach USD 1.14 Billion by 2022 from USD 0.79 Billion in 2017, at a CAGR of 7.6% during the forecast period. Advantages of autosamplers over manual injection systems, growing importance of chromatography in drug approvals, and increasing production of crude and shale oil are some of the key factors driving the growth of the market.
This report broadly segments the autosamplers market into product and end user. On the basis of product, the market is categorized into autosampler systems and autosampler accessories. The autosampler systems segment is further segmented into liquid chromatography (LC) autosampler and gas chromatography (GC) autosampler, while autosampler accessories are further segmented into vials, syringes, needles, and septum. GC autosampler systems are further segmented into three types–liquid, headspace, and all in one.
In 2017, the autosamplers systems segment is expected to account for the largest share. Largest share of this segment is mainly attributed to LC autosamplers systems being adopted rapidly in various industries like pharmaceutical and food & beverages. Based on end user, the autosamplers market is segmented into pharmaceutical and biopharmaceutical industry, oil and gas industry, food and bevarage industry, environmental testing industry, and other end user segment. The pharmaceutical and biopharmaceutical segment is estimated to command the largest share of the global autosamplers market in 2017. Growing importance of chromatography tests in the drug approval process and increasing funds for R&D activities in pharmaceutical and biopharmaceutical industries are key factors driving the growth of the market.
The report covers the autosamplers market across four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the market in 2017 due to the increasing funds for R&D activities in healthcare industries, growing funding for environmental testing and cleanup activities in the US, government initiatives to improve laboratory infrastructure, and government investments for environmental protection in Canada. However, Asia Pacific is expected to register the highest growth rate during the forecast period, due strategic expansions done by some of major players of autosamplers in China, growth in medical and biomedical research in Japan, and the growing pharmaceutical industry in India.
The major players of the autosamplers market are Agilent (US), Waters (US), Shimadzu (Japan), Thermo Fisher (US), and PerkinElmer (US). The other players in this market include Merck (Germany), Bio-Rad (US), Restek (US), Gilson (US), JASCO (US), and SCION (US).
About Us: Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
